Literature DB >> 2184347

Effects of phospholipases, proteases and neuraminidase on gamma-hydroxybutyrate binding sites.

V Hechler1, M Mersel, H Dreyfus, M Maitre.   

Abstract

gamma-Hydroxybutyric acid (GHB) is a natural compound of mammalian brain synthesized from GABA. The characteristics of its synthesis, transport, release, distribution and turnover, in addition to the presence of a high affinity binding site for this substance in brain are in favor of a modulator role for GHB. The effects of hydrolytic enzymes on the specific binding capacity of GHB have been studied in the present work. Phospholipases A2 and C, neuraminidase and Pronase markedly decrease GHB binding to crude synaptosomal membranes from rat brain. This effect is time and enzyme concentration dependent. Trypsin, under the conditions employed, is less active. The inhibitory effects of phospholipases is correlated with phospholipid hydrolysis. Lysophospholipids, in the absence of bovine fatty acid free serum albumin partially inhibit GHB binding. The action of neuraminidase has been followed by sialic acid release and modifications of the ganglioside profile. The effects of phospholipase C and of neuraminidase are completely different to those on GABA binding sites. These results represent further data concerning the molecular existence of specific GHB binding sites on rat brain membranes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184347     DOI: 10.1007/bf00223496

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  The effect of phospholipases and proteases on the binding of gamma-aminobutyric acid to junctional complexes of rat cerebellum.

Authors:  C T Giambalvo; P Rosenberg
Journal:  Biochim Biophys Acta       Date:  1976-07-15

3.  Evidence that a specific succinic semialdehyde reductase is responsible for gamma-hydroxybutyrate synthesis in brain tissue slices.

Authors:  J F Rumigny; C Cash; P Mandel; G Vincendon; M Maitre
Journal:  FEBS Lett       Date:  1981-11-02       Impact factor: 4.124

4.  Regional distribution of high-affinity gamma-[3H]hydroxybutyrate binding sites as determined by quantitative autoradiography.

Authors:  V Hechler; D Weissmann; E Mach; J F Pujol; M Maitre
Journal:  J Neurochem       Date:  1987-10       Impact factor: 5.372

Review 5.  Gamma hydroxybutyrate.

Authors:  O C Snead
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

6.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

Review 7.  Gamma-hydroxybutyrate, a possible neurotransmitter.

Authors:  P Vayer; P Mandel; M Maitre
Journal:  Life Sci       Date:  1987-09-28       Impact factor: 5.037

8.  Depolarization-evoked release of gamma-hydroxybutyrate from rat brain slices.

Authors:  M Maitre; C Cash; D Weissmann-Nanopoulos; P Mandel
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

9.  Direct thin-layer chromatography of gangliosides of a total lipid extract.

Authors:  S Harth; H Dreyfus; P F Urban; P Mandel
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

10.  High affinity binding sites for gamma-hydroxybutyric acid in rat brain.

Authors:  J Benavides; J F Rumigny; J J Bourguignon; C Cash; C G Wermuth; P Mandel; G Vincendon; M Maitre
Journal:  Life Sci       Date:  1982-03-15       Impact factor: 5.037

View more
  1 in total

1.  Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization.

Authors:  Erik J Bonten; Yvan Campos; Viateslav Zaitsev; Amanda Nourse; Brett Waddell; William Lewis; Garry Taylor; Alessandra d'Azzo
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.